Urolog. pro Praxi, 2008; 9(3): 116-119

Viral infections in the etiopathogenesis of prostate cancer: a review

MUDr. Jan Hrbáček, ml, MUDr. Jiří Heráček, MUDr. Tomáš Novotný, doc. MUDr. Michael Urban
Urologická klinika 3. LF UK a FN KV v Praze

In this review, the author summarizes the main studies published dealing with the possible correlation between viral infection and prostate carcinogenesis.

Keywords: prostate cancer, etiopathogenesis, viral infections

Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrbáček ml J, Heráček J, Novotný T, Urban M. Viral infections in the etiopathogenesis of prostate cancer: a review. Urol. praxi. 2008;9(3):116-119.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Balis V. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 2007; 22(4): 245-251. Go to original source... Go to PubMed...
    2. Carozzi F. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 2004; 19(4): 257-261. Go to original source... Go to PubMed...
    3. Dillner J. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Intj. Cancer 1998; 75: 564-567. Go to original source... Go to PubMed...
    4. Grinstein S. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002; 62: 4876-4878.
    5. Hoffman LJ. Elevated seroprevalence of human herpesvirus-8 among men with prostate cancer. J. Infect. Dis 2004; 189: 15-20. Go to original source... Go to PubMed...
    6. Jenkins F. Human herpesvirus-8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis 2007; 196(2): 208-211. Go to original source... Go to PubMed...
    7. Korodi Z. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14(12): 2952-2955. Go to original source... Go to PubMed...
    8. Kuczyk M. Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis. Prost Canc Prost Dis 2000; 3 (Suppl 1): S23. Go to original source... Go to PubMed...
    9. Leiros GJ. Detection of human papilomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005; 5: 15. Go to original source... Go to PubMed...
    10. Noda T. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 1998; 26(3): 165-169. Go to original source... Go to PubMed...
    11. Rosenblatt KA. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev 2003; 12: 763-768. Go to PubMed...
    12. Saad F. Absence of human papillomavirus sequences in early stage prostate cancer. Can J Urol 1999; 6(4): 834-838.
    13. Samanta M. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol 2003; 170: 998-1002. Go to original source... Go to PubMed...
    14. Serth J. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 1999; 59: 823-825.
    15. Sinclair AL. Bladder and prostate cancer screening for human papillomavirus by polymerase chain reaction: conflicting results using different annealing temperatures. Br J Biomed Sci 1993; 50(4): 350-354.
    16. Sitas F. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer 2007; 2(2): 6. Go to original source... Go to PubMed...
    17. Strickler HD. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998, 82: 1118-1125. Go to original source...
    18. Sutcliffe S, et al. Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2007; 16(8): 1573-1580. Go to original source... Go to PubMed...
    19. Suzuki H. Detection of human papillomavirus DNA and p53gene mutations in human prostate cancer. Prostate 1996; 28: 318-324. Go to original source... Go to PubMed...
    20. Terris MK. Human papillomavirus detection by polymerase chain reaction in benign and malignant tissue is dependent on the primer set utilized. Urology 1997; 50(1): 150-156. Go to original source... Go to PubMed...
    21. Wideroff L. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 1996; 28(2): 117-123. Go to original source... Go to PubMed...
    22. Zambrano A. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53: 263-276. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.